(firstQuint)An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults.

 This is an open-label extension study to evaluate long-term safety and tolerability of intravenous (IV) MEDI-546 in adult subjects with moderately-to-severely active systemic lupus erythematosus (SLE).

 Subjects must have completed the qualifying Phase 2 study and meet this study criteria in order to be eligible.

.

 An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults@highlight

The purpose of this study is to evaluate the long-term safety of MEDI-546 in adults with moderate to severe active systemic lupus erythematosus